Ductal shunting and effective systemic blood flow following single dose surfactant treatment in the premature baboon with hyaline membrane disease.
We studied the hemodynamic effects of using natural surfactant in premature baboons with hyaline membrane disease (HMD). Study animals (n = 5) received a single dose of surfactant immediately after delivery and control animals (n = 8) did not. Using microspheres at 3, 8, and 23 h we found no significant differences in left ventricular output, effective systemic flow, systemic-to-pulmonary patent ductus arteriosus (PDA) shunting, or in cerebral or renal organ blood flow. However, both groups had large PDA shunts (fraction of LVO to lungs greater than 0.40-0.55 at 3 and 8 h) resulting in low systemic perfusion (less than 80 ml/min/kg). Single dose surfactant did not improve the myocardial dysfunction and low cerebral and renal blood flow which occur during treatment for HMD.
Kinsella
J P
JP
Department of Pediatrics, Fitzsimons Army Medical Center, Aurora, Col.
Gerstmann
D R
DR
Gong
A K
AK
Taylor
A F
AF
deLemos
R A
RA
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000098:blood supply; D004195:Disease Models, Animal; D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006819:Hyaline Membrane Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007231:Infant, Newborn; D007442:Intubation, Intratracheal; D007668:Kidney / Q000098:blood supply; D008863:Microspheres; D010215:Papio; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D012121:Respiration, Artificial; D012129:Respiratory Function Tests
D011663:Pulmonary Surfactants